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Abstract
Background: Irritable bowel syndrome (IBS), a functional bowel disorder with symptoms of
abdominal pain and disturbed defecation experienced by 10% of U.S. adults, results in significant
disability, impaired quality of life, and health-care burden. Conventional medical care focusing on
pharmacological approaches, diet, and lifestyle management has been partially effective in
controlling symptoms. Behavioral treatments, such as cognitive-behavioral therapy and hypnosis,
are promising. This paper describes an on-going feasibility study to assess the efficacy of mindfulness
training, a behavioral treatment involving directing and sustaining attention to present-moment
experience, for the treatment of IBS.
Methods/Design: The study design involves randomization of adult women with IBS according to
Rome II criteria, to either an eight-week mindfulness training group (based on a Mindfulness-based
Stress Reduction [MBSR] format) or a previously validated IBS social-support group as an attention-
control condition. The primary hypothesis is that, compared to Support Group participants, those
in the Mindfulness Program will demonstrate significant improvement in IBS symptoms as measured
by the IBS Symptom Severity Scale [1].
Discussion: 214 individuals have been screened for eligibility, of whom 148 were eligible for the
study. Of those, 87 were enrolled, with 21 withdrawing after having given consent. 66 have
completed or are in the process of completing the interventions. It is feasible to undertake a
rigorous randomized clinical trial of mindfulness training for people with IBS, using a standardized
MBSR protocol adapted for those experiencing IBS, compared to a control social-support group
previously utilized in IBS studies.
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Irritable bowel syndrome (IBS) is a functional bowel dis-
order characterized by symptoms of abdominal pain or
discomfort associated with disturbed defecation [2], expe-
rienced by about 10% of the U.S. adult population (14%
women, 8% men), and resulting in disability, impaired
quality of life, and health-care burden [3-5]. Conven-
tional medical care for IBS has focused on diet and life-
style management (e.g. exercise and stress reduction),
behavioral treatments, and a range of pharmacological
approaches, particularly antispasmodics [6]. Pharmaco-
logical therapies, which often bear significant costs and
side effects, may relieve symptoms temporarily but sel-
dom correct underlying causes. Behavioral treatments,
such as cognitive-behavioral therapy and hypnosis, have
shown positive results, reflecting the importance of a
biopsychosocial perspective.
Mindfulness meditation is a unique behavioral technique
which involves the intentional self-regulation of attention
by learning to attend to present-moment experience and
letting go of cognitive fixation on thoughts of past and
future, thus inducing a non-evaluative metacognitive
state. Mindfulness practice has been shown to reduce
symptoms of stress and pain and ameliorate the symp-
toms of fibromyalgia and depression [7-11]. There is little
research, and no well controlled clinical trials, on its effi-
cacy specifically for IBS. One small, uncontrolled pilot
study at UNC found decreased symptom severity in
patients with IBS following an eight-week mindfulness-
training program [12].
A study of mindfulness for treatment of IBS is warranted
for the following reasons: 1) mindfulness training has
been shown to be associated with significant symptom
reduction in disorders in which both pain and stress are
prominent; 2) the techniques of mindfulness can be
taught effectively in groups; 3) mindfulness programs are
taught as wellness programs, with participants typically
reporting positive changes in life-style in addition to
improved stress and pain management; 4) as wellness
programs, mindfulness can be taught safely and effec-
tively by instructors who may be unlicensed in other dis-
ciplines but well-trained in mindfulness; 5) participants
report high levels of satisfaction and drop-out rates are
low.
Mindfulness meditation may be uniquely suited to treat
the underlying psychological symptoms associated with
IBS: these include an increased sensitivity to pain from
intestinal distention [13] that is correlated with anxiety
about the significance of these sensations [14] and selec-
tive attention to gastrointestinal sensations [15]. Indeed,
recent cognitive neuroscience investigations have found
that mindfulness meditation induces alterations in the
activation of neural circuits implicated in neurovisceral
awareness, interoception (sensitivity to internal stimuli),
and self-regulation [16,17]. Additionally, mindfulness
has been shown to improve ability to control attentional
processes [18-21]. Given these findings, it seems plausible
that mindfulness may exert a salutary effect on irritable
bowel symptomatology and perhaps even the underlying
mechanisms of the syndrome.
In this paper, we describe an ongoing feasibility study to
assess the efficacy of a program of mindfulness-based
stress and pain management (Mindfulness Program) for
treatment of IBS-related symptoms in women. The study
includes baseline assessments in patients with docu-
mented IBS with subsequent randomization to one of two
treatment arms: 1) Mindfulness Program (the interven-
tion group); and 2) an IBS Support Group (the control
group) previously validated as an effective placebo-con-
trol condition in a randomized controlled trial of cogni-
tive behavior therapy for the treatment of IBS [22].
Outcomes are evaluated at the end of treatment and at 3,
6, and 12 months follow-up.
The study's primary aim is to determine the feasibility of
developing a clinical trial comparing effectiveness of a
Mindfulness Program with an IBS Support Group in
reducing the severity of symptoms in women with IBS.
The primary hypothesis is that, compared to those in the
Support Group, those in the Mindfulness Program will
demonstrate significant improvement in IBS symptoms,
as measured by the IBS Symptom Severity Scale [1].
Aim two is to identify appropriate secondary outcomes in
the Mindfulness Program and IBS Support Groups,
including psychological symptoms, coping strategies, and
quality of life. We hypothesize that, compared with those
in the Support Group, those in the Mindfulness Program
will experience significant reductions in anxiety, depres-
sion, anger, and maladaptive coping strategies, as well as
improvements in quality of life and effective occupational
functioning. Analysis of these variables will lead to better
estimates of effect sizes and powering of future studies,
and will guide the selection of outcome measures and the
design and analyses for those studies.
A third aim is to compare two currently available process
measures of mindfulness – the Five Facet Mindfulness
Questionnaire (FFMQ) [18-21] and the Toronto Mindful-
ness Scale (TMS) [23], specifically testing: a) how well the
FFMQ vs. the TMS are able to detect any differences in
treatment groups; and b) whether either of these scalesPage 2 of 11
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gram who are ranked as more successful at learning and
practicing mindfulness from those who are less successful.
Methods/Design
Figure 1 illustrates the overall design and subject flow
through the study. Study procedures and consent forms
were reviewed and approved by the Institutional Review
Board of The University of North Carolina at Chapel Hill
(UNC).
Hypotheses
The primary hypothesis is that, compared to those in the
Support Group, those in the Mindfulness Program will
demonstrate significant improvement in IBS symptoms,
as measured by the IBS Symptom Severity Scale [1]. Sec-
ondary hypotheses are that, compared with those in the
Support Group, those in the Mindfulness Program will
experience significant reductions in anxiety, depression,
anger, and maladaptive coping strategies, as well as
improvements in quality of life and effective occupational
functioning.
Eligibility
Included in this trial are women at least 18 years old who
have a medical diagnosis of IBS and who also meet the
Rome II criteria for IBS [24]. Subjects must be able to
understand English and be willing and able to document
regularly their IBS symptoms and medication use as well
as complete the assessment instruments. Subjects must be
willing to attend 8 weekly 2-hour Mindfulness Program or
Support Group sessions plus a half-day Saturday session.
All subjects are informed that they should continue to
receive usual care from their primary care or specialist
physicians and that no specific recommendations for
changes in medications for IBS or other medical issues
will be made by the research team.
Excluded are subjects with the following conditions: 1)
diagnosis of mental illness with psychotic features; 2) a
history of an inpatient admission for psychiatric disorder
within the past two years; 3) a history or current symp-
toms of inflammatory bowel disease or gastrointestinal
malignancy; 3) active liver or pancreatic disease; 4)
uncontrolled lactose intolerance; 5) celiac disease; 6) a
history of abdominal trauma or surgery involving gas-
trointestinal resection; or 7) pregnancy or intention to
become pregnant during the study.
Recruitment
Patients under the care of the UNC Health Care System or
local community physicians are recruited through several
sources: 1) advertisements on the website of the UNC
Center for Functional GI and Motility Disorders http://
www.med.unc.edu/ibs; 2) newspaper advertisements; 3)
an existing IBS patient registry; 4) posters and brochures;
and 5) mass e-mailings to UNC list-serves. Additionally,
physicians are asked to inform patients with IBS about the
study, describing it as a psychological support interven-
tion to be carried out in addition to their usual conven-
tional therapy for IBS. Study participants are remunerated
for completing the assessments and as well as for complet-
ing the assigned intervention (defined as attendance at a
minimum of six of the nine sessions).
Screening, consent, and enrollment
Prospective subjects are screened by telephone by the
study coordinator. If an individual is eligible for the study
and wishes to participate, the study coordinator schedules
a meeting at a mutually convenient time and location to
explain the study, obtain informed consent, and complete
initial assessments. A psychosocial assessment and gas-
trointestinal medical questionnaire is completed at this
visit or shortly thereafter. Subjects are told that they may
have to wait a short time for classes to begin while addi-
tional subjects are being recruited. Classes are scheduled
to begin when a minimum of 6 subjects have been rand-
omized to each of the two groups.
Randomization
Upon completion of the baseline interview and question-
naires, eligible women are randomized by computer to
the Mindfulness Program or IBS Support Group. This
process eliminates experimenter bias in group assign-
ment. The computer program uses a random number gen-
erator and is programmed to insure equal numbers of
subjects in each arm of the study within a variable block
size of 4–8 subjects. The computer program generates a
treatment assignment and a study ID number associated
Overall Design and Subject FlowFigure 1
Overall Design and Subject Flow.
Screen Women with IBS
Consent and randomize eligible women
Baseline assessments with demographics
8 wks Mindfulness training 8 wks Support group
2 weeks post
Outcome assessment
25% Not eligible
12% Not available
17% drop before 
intervention start
2 weeks post
Outcome assessment
3 months post
Primary outcome assessment
3 months post
Primary outcome assessment
6 months post
Outcome assessment
6 months post
Outcome assessment
12 months post
Outcome assessment
12 months post
Outcome assessment
14% Drop 
during 
intervention
8% did not  
return 
usable dataPage 3 of 11
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uments these in an uneditable form with a date stamp.
Masking
The nature of the interventions does not allow masking of
treating physicians, subjects or instructors. To minimize
differences in subject expectancy, the experimental inter-
ventions are described to subjects only as two psycholog-
ical interventions – a set of meditation procedures and a
support group – both of which have been reported in pre-
vious studies to benefit patients with IBS. The intent is to
prevent subjects from knowing which intervention the
investigators believe is most likely to improve symptoms.
To verify that patients assigned to the Support Group have
the same expectation of benefit as patients assigned to the
Mindfulness Program, all patients complete a Credibility
Scale [25] after the first treatment session. This scale is pre-
sented to the subjects as an "early evaluation" scale.
Follow-up questionnaires are printed and mailed to sub-
jects for completion. To maintain masking of staff
involved in data input and analysis and to prevent bias,
returned questionnaires bear only a research number.
The Intervention Group – Mindfulness for Irritable Bowel 
Syndrome
The mindfulness-based stress and pain management pro-
gram (Mindfulness Program) was based on the Mindful-
ness-Based Stress Reduction (MBSR) program developed
by Jon Kabat-Zinn and Saki Santorelli at the University of
Massachusetts. MBSR is a flexible program, adaptable to a
variety of patients with wide-ranging symptoms [26]. The
modification introduced was to emphasize symptoms
and perceptions concerning IBS when teaching about
mindfulness, as well as in group discussion. For example,
it is suggested to participants that they might notice any
sensations in the abdominal area and distinguish those
sensations from thoughts about sensations. In so doing,
the mindfulness intervention targets maladaptive cogni-
tive coping styles such as catastrophizing, which have
been shown in the literature to exacerbate irritable bowel
symptoms [27,28].
In keeping with the MBSR program, the Mindfulness Pro-
gram consists of one 2-hour session each week for 8 con-
secutive weeks plus a Saturday retreat near the end of the
intervention. For the Saturday retreat setting of the Day of
Mindfulness, we shortened the length of the day from six
to four hours to match the length of time of the Support
Group's Saturday session.
Class 1
The course begins with personal introductions to create
group cohesion, an overview of the coming eight weeks,
and a discussion of attitudes that support mindfulness.
Participants are led through an experiential exercise that
focuses on the immediacy of physical sensations and dif-
ferentiates sensations from thoughts about sensations;
they are encouraged to take this practice home as mindful
eating. They are introduced to diaphragmatic breathing.
Participants are then led through a lengthy scan of body
sensations to facilitate non-judgmental awareness; this
exercise is also assigned as part of routine home practice,
along with weekly readings of relevant chapters in "Full
Catastrophe Living" and "IBS for Dummies."
Class 2
Participants are guided through the body scan at the
beginning of class. They are then encouraged to share and
discuss their experiences during the preceding week, par-
ticularly with regard to home practice. Participants are
introduced to sitting meditation with awareness of breath-
ing as the primary object of attention, partially for the pur-
pose of developing concentration. This form of
meditation is added to the daily home practice, along
with continuation of the body scan and new readings. The
role of subjective interpretation is also presented as a way
of beginning to understand personal responsibility for
one's thoughts and actions. Home practice this week also
includes awareness of pleasant events and of a routine
daily activity.
Class 3
Gentle mindful yoga movements are introduced as a way
of alleviating physical symptoms of stress and bringing
awareness to subtle movements of the body. The discus-
sions include the power of being in the present moment
and the objective observation of thoughts as merely
thoughts, rather than as facts or events. Home practice now
includes body scan, gentle yoga, sitting meditation with
focus on breathing, awareness of unpleasant events, and
awareness of a different routine activity.
Class 4
The practice of sitting meditation is expanded to empha-
size the perception of body sensations as simply sensations
(as opposed to interpretations and thoughts about sensa-
tions, e.g. catastrophizing). Walking meditation is also
introduced. The psychophysiology of the stress response
is presented. Recommended home practice at this point
consists of alternating body scan, gentle yoga, walking
meditation, sitting meditation (for a longer period of
time), and bringing awareness to both stress reactions and
to moments of going numb or shutting down.
Class 5
Acknowledging the halfway point in the course, partici-
pants discuss commitment to daily practice and their
experiences of the effects of the program so far. Sitting
meditation is expanded to include awareness of thoughtsPage 4 of 11
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role of mindfulness in responding to stress in everyday
life. The concept of emotional intelligence is introduced.
For home practice, participants are encouraged to begin
experimenting with combinations of practices previously
introduced that fit their needs, including body scan, gen-
tle yoga, walking meditation, and sitting meditation.
Home practice also includes a difficult communications
exercise and awareness of the distinction between every-
day reacting (without choice) and responding (with
choice).
Class 6
Sitting meditation continues to lengthen and deepen via
guided practice sessions that include use of metaphors
that explore qualities of mindfulness. The topic of work-
ing with emotions continues from the previous class,
expanding the inner resources for emotional resilience. In
addition to the home practices suggested previously, par-
ticipants are asked to be aware of and label their emotions
for the next week.
Half-day Retreat
Most of the time is spent in silence, with alternating peri-
ods of sitting meditation, walking meditation, gentle
mindful yoga, a body scan, and an introduction to a
guided loving-kindness meditation. A discussion period
at the end allows participants to share their experiences,
challenges, and insights.
Class 7
The practice of choiceless awareness is introduced to the sit-
ting meditation. Choiceless awareness is a state in which
one is fully aware of the moment, yet mindfulness is not
focused on any physical or mental image or object. Topics
of discussion include gaining confidence in the practice
and results of mindfulness, awareness as related to food
and eating, and experiences in everyday life following the
half-day retreat. In addition to the home practices sug-
gested previously, attention is drawn to awareness of how
we nourish our bodies, and how that relates to emotional
intelligence.
Class 8
Class begins with a body scan, followed by sitting medita-
tion. The discussion focuses on a brief review of the
course, acknowledging where the participants are at this
point in their personal practices, and cultivating resources
for continued practice.
Homework assigned each week throughout the course
includes daily mindfulness practices and readings from
two provided texts, "Full Catastrophe Living" [26] and "IBS
for Dummies" [29]. Subjects are asked to keep a daily diary,
including minutes of practice time and any IBS symp-
toms. Subjects may choose to record diary information
either electronically (submitted daily) or on paper (sub-
mitted weekly at the meetings or mailed).
The Control Condition – IBS Support Group
We selected a social-support group intervention led by
master's level social workers as the control condition. This
format was selected to control for subject credibility,
expectations, and attention, providing regular group con-
tact, a group leader, and a structure similar to the Mindful-
ness Program group, while excluding the active elements
of the Mindfulness Program. A similar control condition
was used successfully in a previous study testing the effec-
tiveness of cognitive behavior therapy for the treatment of
IBS [22]. In that study, the Support Group arm was found
to produce an expectation of benefit comparable to the
cognitive behavior therapy group but less actual change in
IBS symptoms than cognitive behavior therapy.
In parallel with the Mindfulness Program, the Support
Group sessions consist of one 2-hour session each week
for 8 consecutive weeks plus one half-day Saturday ses-
sion during the second half of the intervention. The half-
day session involves the preparation and sharing of an
"IBS-friendly" meal by Support Group participants.
Weekly Support Group sessions focus on specific pre-des-
ignated topics and involve open group discussions about
subjects' experiences with, or reaction to, the topic. Ses-
sion topics, in the following order, include: (a) reasons for
attending the Support Group; (b) personal experience of
IBS symptoms; (c) triggers for IBS symptoms; (d) medical
concerns related to IBS assessment or treatment; (e)
changes in IBS symptomatology over time; (f) the impact
of diet and exercise on IBS; (g) social relationships and
IBS; and (h) review of the Support-Group experience.
Each session begins with an introduction of the specific
IBS-related topic by the group leader. Subjects are encour-
aged to provide examples from their own life experiences
to enhance each other's understanding of the topic.
Although Support Group leaders facilitate discussion and
answer questions, they do not give didactic information,
behavioral prescriptions, or advice. Instead, the role of the
group leader is to prompt participants with questions,
facilitate discussion, and maintain an environment where
disclosure is possible. To that end, leaders ask open ended
questions, and promote discussion by using probes such
as asking for clarification, requesting explanations, and
encouraging cross-talk between group members. If sub-
jects ask the group leader a direct question about how to
manage their IBS symptoms, the group leader responds by
redirecting the question to the group and urging partici-
pants to share their own coping strategies with one
another.Page 5 of 11
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includes readings from the provided text, "IBS for Dum-
mies" [29]. Subjects are asked to write a journal entry
about the discussion topic for the coming week as it
relates to their personal experience with IBS, as well as to
keep a daily diary of IBS symptoms. Subjects may choose
to record journal/diary information either electronically
(submitted daily) or on paper (submitted weekly at the
meetings or mailed).
Outcome measures and study instruments (See Table 1)
Administration of the outcome and process measures for
Specific Aims 1 and 2 takes place upon entry into the
study, at the completion of the 8-week programs, and
again at 3, 6, and 12 months after program completion.
Collection of these data requires approximately one hour
of subject time at each of the 5 measurement visits.
Primary outcome variable
Irritable Bowel Symptom Severity Scale (IBSS)
The IBSS is a validated brief measure of IBS severity.
Responders rate retrospectively, for the past 10 days,
abdominal pain severity and frequency (separate ratings),
bloating severity, dissatisfaction with bowel habits and
life interference from bowel symptoms. These five ratings
are totaled to obtain an overall rating of IBS severity. The
IBSS has been shown to be valid and reliable [1]; it was
found to discriminate IBS patients from controls, and to
Table 1: Measures for the Mindfulness and Support Group Subjects
Construct Measure Administration
Primary Outcome measure
Symptom Severity Irritable Bowel Symptom Severity Scale Pre, 2 wk, 3 mo, 6 mo, 12 mo post
Secondary Outcome measures
Symptom frequency Daily Symptom Diary Daily during the intervention and for 2 weeks 
post
IBS-related anxiety Visceral Sensitivity Index Pre, 2 wk, 3 mo, 6 mo, 12 mo post
Economic impact of IBS The Work Productivity and Activity Impairment 
for IBS (WPAI: IBS)
Pre, 2 wk, 3 mo, 6 mo, 12 mo post
Co-Morbid Symptoms Recent Physical Symptoms Questionnaire 
(RPSQ)
Pre, 2 wk, 3 mo, 6 mo, 12 mo post
General psychological distress Brief Symptom Inventory (BSI) Pre, 2 wk, 3 mo, 6 mo, 12 mo post
Anger and its expression The State-trait Anger Expression Inventory 
(STAXI)
Pre, 2 wk, 3 mo, 6 mo, 12 mo post
Maladaptive coping methods Coping Strategies Questionnaire (CSQ) Pre, 2 wk, 3 mo, 6 mo, 12 mo post
Quality of life specific to IBS IBS-QOL Pre, 2 wk, 3 mo, 6 mo, 12 mo post
Effect modification measures
Expectancy of success of intervention Borkovec and Nau credibility scales Prior to second session
Catalogue of distressing prior events Family Inventory of Life Events (FILE) Pre intervention only
Demographics Age, race, education, marital status, income Pre intervention only
Process measures
Measure of mindfulness: Multiple constructs Five Facet Mindfulness Questionnaire (FFMQ) Pre, 2 wk, 6 mo, 12 mo post
Measure of mindfulness: Acceptance construct Toronto Mindfulness Scale Pre, 2 wk, 6 mo, 12 mo postPage 6 of 11
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erate, and severe by independent clinical assessment. In a
study of 1603 patients with functional bowel disorders
including 815 who met Rome II criteria for IBS [30], the
IBSS correlated well (Spearman's rho = .66; p < .0001)
with the Functional Bowel Disease Severity Index [1] and
also correlated with the frequency of medical clinic visits
for IBS in the prior 6 months (r = .21; p < 001). In their
systematic review of outcome measures in IBS clinical tri-
als, Bijkerk and colleagues ranked the IBSS as one of the
two best outcome measures for IBS trials based on psycho-
metric properties [31].
Secondary outcome variables
Daily Gastrointestinal Symptom Diary
The symptom diary was adapted from Blanchard et al.
[32] Subjects are asked to complete daily symptom ratings
on the Internet, using a password-protected web page, or
on a paper version of the same diary. On separate 0–4
scales, subjects rate how much of a problem they have had
in the past day with abdominal pain and tenderness, con-
stipation, diarrhea and bloating. They are also asked to
record whether symptoms interfered with eating, drinking
or their usual activities, and how many minutes they did
homework related to the study. A space is provided for
other comments.
Brief Symptom Inventory-18 (BSI-18)
The BSI is an 18-item version of the Symptom Checklist-
90-R (SCL-90-R) [33]. Subjects rate how much they were
bothered in the last 7 days by each of 18 symptoms,
including separate scores for anxiety, depression, somati-
zation, and a global symptom severity index. The BSI has
good internal consistency reliabilities (Cronbach's alpha
= 0.71–0.85) and test-retest reliabilities (α = 0.68 – 0.91)
as well as excellent convergent validity with the SCL-90-R
(r = 0.92–0.98) [34].
IBS-Quality of Life (IBS-QOL)
The IBS-QOL questionnaire is a 34-item disease-specific
quality-of-life scale that measures changes in physical and
psychosocial functioning as a result of IBS. It is responsive
to change over 12 weeks [35] and has high internal con-
sistency (Cronbach's alpha = .95) and high reproducibil-
ity over a 7-day interval (ICC = .86) [30].
State-trait Anger Expression Inventory (STAXI)
This is a 44-item questionnaire that measures State Anger
and Trait Anger [36]. Internal consistency for State and
Trait Anger is good (α = 0.86–0.93) and it correlates well
with hostility indices on the MMPI [37]. In a test of the
effectiveness of an 8-week meditation intervention for
patients with chronic low back pain, the State Anger meas-
ures decreased from pre- to post-intervention: F(1,15) =
3.38, p = 0.09 [38].
Visceral Sensitivity Index (VSI)
The VSI is a 15-item scale which measures anticipatory
anxiety with respect to the likely occurrence of symptoms
such as abdominal pain [39]. Internal consistency is excel-
lent (Cronbach's α = 0.93, inter-item correlation = 0.47),
and the VSI shows good convergent validity with the Hos-
pital and Depression (HAD) Anxiety subscale (r = 0.73)
and the Anxiety Sensitivity Index (ASI) (r = 0.66). Regres-
sion analysis revealed that the VSI is a strong predictor of
symptom severity, accounting for 24% of the variance
[39].
Recent Physical Symptoms Questionnaire (RPSQ)
This 26-item scale was developed by the UNC Center for
Functional Gastrointestinal and Motility Disorders by sys-
tematically reviewing the literature to identify the somatic
symptoms reported with increased frequency by patients
with IBS [40]. Patients are asked to rate the frequency of
occurrence of these symptoms in the last 30 days on a 5-
point ordinal scale. The internal consistency (Cronbach's
alpha) for this questionnaire is 0.86. The RPSQ correlates
strongly with number of physician visits in the past year (r
= .62).
Work Productivity and Activity Impairment for IBS (WPAI: IBS)
The WPAI: IBS measures work-time lost and activity
impairment secondary to IBS. The WPAI: IBS was evalu-
ated for accuracy and validity with 135 IBS patients in
2004 [41]. The sum for missed work time in a retrospec-
tive diary was predictive of the WPAI: IBS score. Test-retest
correlations were high (r = 0.97 – 0.99) as well [41].
Coping Strategies Questionnaire (CSQ)
The 50-item CSQ was designed to assess coping strategies
used by patients who have chronic illness [42]. The 6-item
Catastrophizing subscale, the most frequently used sub-
scale, has excellent internal consistency (alpha = .91) and
correlates with measures of pain intensity and functional
impairment. Three other subscales – Distraction, Ignoring
Pain Sensations, and Distancing from Pain – have good
internal consistency reliability (α = 0.80 – 0.83) and con-
tain items that may distinguish between the two groups at
outcome, in terms of coping styles.
Moderators
Demographics
The study is limited to women. The demographic ques-
tionnaire collects data about each woman's age, marital
status, race/ethnicity, years of education, approximate
family income, and medical history related to IBS.
Family Inventory of Life Events and Changes (FILE)
The FILE was designed to assess the accumulation of
stressful events experienced by a family [43]. Reliability is
well established for the full scale (α = 0.72 – 0.81),Page 7 of 11
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bility for the full scale is good (r = 0.72 – 0.77).
Evaluation of Subject Expectation/Bias and Protocol Variability
Credibility scale (Attitude Towards Treatment Questionnaire)
This measure was based on the original measure by Bork-
ovec and Nau which assesses patients' expectations of
benefit once treatment has been explained [25]. The scale
has been found to distinguish between standard psycho-
therapy approaches and illogical placebo treatments, it is
predictive of clinical improvement, and it is relatively
independent of symptom severity. Although originally
designed to focus upon treatments for fear, Drossman,
Toner, and Whitehead modified the questions to target
psychological (and placebo) treatments of functional gas-
trointestinal disorders [44].
Quality Control (See Table 2)
Instructors record attendance, logistical problems and
other study-related issues. The study coordinator keeps a
similar log of logistical issues and contacts subjects not
completing the intervention to evaluate factors leading to
dropout. To evaluate subject engagement, subjects are
prompted to keep a log of their homework practice in
their daily diaries.
To evaluate intervention fidelity, we measure instructor
adherence to protocol through videotaping the second
and seventh Mindfulness Program and IBS Support Group
sessions with an unmanned stationary video recorder.
Video-taping is for purposes of identifying variations in
instructor attitude, communication bias and systematic
variations in behavior between treatment groups. It is also
used to assess adherence to protocol as well as to screen
for any group-dependent differences in content or style of
communication between the instructor and participants.
Process Measures
Five Facet Mindfulness Questionnaire (FFMQ)
The FFMQ was developed by Baer based on exploratory
and confirmatory factor analyses of five existing question-
naires designed to explore constructs of mindfulness iden-
tified in prior research [45]. The resulting instrument is a
39-item, Likert-type measure assessing five identified fac-
ets of mindfulness: non-reactivity to inner experience;
non-judging of inner experience; acting with awareness;
describing; and observing. Individual facets of the FFMQ
correlate positively with openness to experience, emo-
tional intelligence, and self compassion, and negatively
with alexethymia, dissociation, and psychological distress
[45].
Toronto Mindfulness Scale
The Toronto Mindfulness Scale adapted by J. Kristeller
measures the acceptance construct in mindfulness. The
scale is currently undergoing reliability and validity test-
ing [23].
Adverse events
All subjects are asked to record any adverse events in their
diaries and to report them to the group leaders, the study
coordinator or the study physician. In addition, they are
asked about their experiences weekly at the training ses-
sions. Subjects are also strongly encouraged to discuss
with the research staff anything they feel to be an adverse
event or other issues that are problematic for them about
the study.
Analytic strategy
Sample Size and Power Calculation
Outcome measures for clinical trials were investigated,
including a report of adequate relief of IBS symptoms and
the magnitude of symptom reduction on the IBSS, our pri-
mary outcome in this trial [46]. Based on this data,
patients reporting "adequate relief," defined here as a clin-
ically meaningful outcome, showed a reduction in IBSS
scores of 87 units. The power to detect this change at α =
.05 in samples of 30 per group is approximately 84%. In
the current study, 45 subjects per group is planned.
Regression modeling will be used to test the primary
hypothesis. A simple linear regression model with the
IBSS score at the end of the study controlling for IBSS
score at the baseline will be used to test for significant
Table 2: Quality Control and Feasibility Measures
Component Measure Responsible party
Context Log of comments about space, contacts with other interested parties outside of participants Instructors
Study coordinator
Dose delivered Attendance log
Enrollment diary
Instructors
Study coordinator
Dose received Participant log of adherence to homework assignments Instructors
Fidelity Video-taping of instructors delivering interventions Research assistant, PIPage 8 of 11
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on IBSS measures to detect whether the change in IBSS
scores differ significantly between the two groups. Because
of the correlated nature of the repeated measures, regres-
sion models using a generalized estimating equations
(GEE) approach will be used to test the hypothesis of
change. A significant time and treatment interaction will
detect significant changes in the score. A similar analysis
strategy using GEE methods will be used to analyze daily
records of IBS symptoms. All data analysis will be per-
formed on an intent-to-treat basis. The GEE method
assumes that missingness in data are completely at ran-
dom. Under the missing at random assumption, it is pos-
sible to conduct analyses using multiple imputation
procedures [47].
Discussion
Recruitment into the study has proceeded as planned,
with subjects being recruited via the UNC Center for Gas-
trointestinal Disorders Subject Registry, as well as through
flyers, email announcements, and newspaper advertise-
ments. At present, 214 individuals have been contacted to
screen for eligibility. Of those, 127 did not qualify: 66
were ineligible (previous meditation training, non-IBS
bowel disease, psychiatric disorder, diabetes, and lactose
intolerance), 32 declined participation (in the area only
temporarily, moved away, incompatible schedule, symp-
tom free now), and 29 asked to be contacted later.
Eighty-seven subjects have been enrolled so far, of whom
21 withdrew (14 in Mindfulness/7 in Support group): 10
withdrew before attending a class and 11 others withdrew
after one or more classes. Reasons for withdrawal
included pregnancy, family illness, new medication,
schedule changes, and moving). Sixty-six have completed
or are in the process of completing the study. There have
been no reported adverse events related to the study.
This report endorses the feasibility of undertaking a rigor-
ous randomized clinical trial of mindfulness training for
people with IBS, using a standardized MBSR protocol
adapted for those experiencing IBS, compared to a control
social-support group previously utilized in IBS studies
and adapted here.
Final analysis of the data is not yet available for compar-
ing the two intervention groups in terms of protocol cred-
ibility, satisfaction, or the primary and secondary
outcomes. However, several preliminary conclusions can
be made at this point.
Feasibility
Although recruitment has been challenging, our primary
aim of proving feasibility has been achieved. Subjects
completed the study measures in a timely fashion with
minimal assistance and fairly good compliance. Subject
diaries have been a rich source of information and future
studies will put more emphasis on diary compliance.
Other aims, including acquisition of secondary outcome
measure data and mindfulness measurement assessment
tools, have also been achieved. Recruitment will continue
through June 2009, with data analyses to follow.
Recruitment challenges
Both interventions require subjects to commit to attend-
ing nine group sessions over a period of eight weeks. The
busy lives of many women, especially those with chronic
conditions such as IBS, may preclude their making such a
long commitment. In addition, competing IBS studies at
UNC with shorter time commitments and higher com-
pensations have made this opportunity less appealing to
some. Despite these challenges, significant efforts on the
part of the research staff and our research fellows have
ensured that adequate numbers of subjects have been
available for study.
Group Assignment and Credibility
A large majority of participants in both groups have
expressed satisfaction with their group assignment and
the drop-out rate has been reasonably low after exposure
to the two interventions. Preliminary assessment of inter-
vention credibility reveals that there is no major barrier to
completion of the study for members of either group.
Minority Recruitment
We have had success in recruiting minorities for the study
(approximately 19% African-American, 2% Hispanic/
Latina). Since the study requires participants to communi-
cate adequately in English in group discussions, we have
not targeted those who do not speak English.
Study Benefits
The benefits to subjects may be significant. First, the
symptoms experienced by the subjects may improve sig-
nificantly as a direct result of being part of the study. All
subjects undergo an evaluation of their IBS symptoms,
coping strategies and psychological factors that influence
the course of their condition. Prior research suggests that
mindfulness training may be useful as adjunctive treat-
ment for a number of disorders associated with IBS that
may be present in members of the study cohort. Subjects
in both groups may experience greater clinical improve-
ment than they might otherwise experience with usual
medical care alone. The process of participating in the
Mindfulness Program or the Support Group could
enhance self-efficacy. Participants may learn improved
methods of managing IBS from each other's experience.
Results of this project will provide important information,
in addition to addressing the feasibility of conducting aPage 9 of 11
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to issues of integration of mindfulness meditation with
conventional medical care; application of mindfulness for
IBS; use of a support-group control; and statistical
approaches as described in the Methods/Design section.
Knowledge gained about issues of control therapies in
CAM research, subject recruitment and measurement
methods may be of broader significance to the develop-
ment of clinical trials using other CAM modalities.
We will also gain evidence for or against the integration of
mindfulness with usual medical care for treatment of a
common and debilitating disease. Results supporting the
use of mindfulness will lead to expanded studies of this
modality, powered to define more clearly the magnitude
of benefits and the scope of its clinical uses. If the use of
mindfulness for IBS is supported by future studies, mind-
fulness-based treatment of IBS could potentially diminish
IBS patients' conventional health care utilization, with its
associated side effects and substantial costs.
Additionally, a well-conceived and adequately powered
clinical trial based on our study showing positive results
could further elucidate the mechanism of action of mind-
fulness, which remains largely putative at this point.
Knowledge derived from this and follow-up studies could
enhance our understanding of human psychobiology
from the standpoint of health maintenance and healing in
ways that have not been fully appreciated or conceptual-
ized to date.
By clarifying methodological issues, such as subject
accrual, design of control interventions, effect size estima-
tion, and whether a definitive trial is even warranted, the
results of this study may help others conducting research
in mind-body medicine to improve the nature and quality
of their research and open the way for future definitive
studies.
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